Canada Markets open in 6 hrs 56 mins

Panbela Therapeutics, Inc. (PBLA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4500-0.0800 (-5.23%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.09
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 34.7800
52 Week Low 31.4500
50-Day Moving Average 31.8240
200-Day Moving Average 31.9687

Share Statistics

Avg Vol (3 month) 317.63k
Avg Vol (10 day) 312.54k
Shares Outstanding 513.43M
Implied Shares Outstanding 6N/A
Float 811.56M
% Held by Insiders 112.54%
% Held by Institutions 110.01%
Shares Short (Apr 28, 2022) 4142.21k
Short Ratio (Apr 28, 2022) 48.25
Short % of Float (Apr 28, 2022) 41.15%
Short % of Shares Outstanding (Apr 28, 2022) 41.06%
Shares Short (prior month Mar 30, 2022) 4160.64k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov 07, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:1
Last Split Date 3Dec 07, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-55.16%
Return on Equity (ttm)-108.63%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-10.13M
Diluted EPS (ttm)-0.6950
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)11.87M
Total Cash Per Share (mrq)0.88
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.62
Book Value Per Share (mrq)1.00

Cash Flow Statement

Operating Cash Flow (ttm)-6.7M
Levered Free Cash Flow (ttm)-3.36M